Deutsche Bank’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Deutsche Bank’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,050	Closed	-$43K	–	5571
2015 Q2	$43K	Buy	+1,050	New	+$37.6K	﹤0.01%	4660

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Deutsche Bank's BRLI Position: Q3 2015 in Review

Deutsche Bank sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 154,820 shares — an estimated $6.38M sold.

Deutsche Bank first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $6.38M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Deutsche Bank reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Deutsche Bank sold 154,820 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $6.38M.
Deutsche Bank first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
Deutsche Bank's BIO-REFERENCE LABS INC-NEW- position peaked at $6.38M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Deutsche Bank's 13F filing for Q3 2015, filed 17 Nov 2015.